URGN UroGen Pharma Ltd
- 12.700
- +0.040+0.32%
- 12.700
- 0.0000.00%
UroGen Pharma Ltd News
UroGen Pharma Ltd | 10-Q: Q3 2024 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025
UroGen Pharma Ltd | 10-Q: Q2 2024 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
UroGen Pharma Ltd | 10-Q: Q1 2024 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
UroGen Pharma Ltd | 10-K/A: Annual report (Amendment)
UroGen Pharma Ltd | 10-K: FY2023 Annual Report
UroGen Pharma Ltd | 10-Q: Q3 2023 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports Third Quarter 2023 Financial Results
UroGen Pharma Ltd | 10-Q: Q2 2023 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Meets Revenue Goal, Reports First Quarter 2023 Financial Results and Recent Corporate Developments
UroGen Pharma Ltd | 10-Q: Q1 2023 Earnings Report
UroGen Pharma Ltd | 10-K/A: Annual report (Amendment)
UroGen Pharma Ltd | 10-K: FY2022 Annual Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
UroGen Pharma Ltd | 10-Q: Q3 2022 Earnings Report
UroGen Pharma Ltd | 10-Q: Q2 2022 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
UroGen Pharma Ltd | 8-K: UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Developments
Analysis
Price Target
No Data
No Data